Israel
Medtechnica is a long-standing player in the health care industry, having been founded in 1953. The company takes pride in its commitment to bringing breakthrough and innovative medical technologies to the market, aiming to improve people’s quality of life. By leveraging strategic partnerships within the MedTech industry, Medtechnica offers comprehensive solutions across a wide range of products and services. Its customer base includes public and private medical centers, health maintenance organizations, and governmental entities such as the ministry of health and the ministry of defense. Additionally, the company's collaboration extends to EMS and local distributors.
Medtechnica operates as part of the Ilex Group alongside Flight Medical, Orsyx, and Ilex, a company that has been publicly traded on the Tel Aviv Stock Exchange since 1995 and is included in the TA-125 index. The company's core businesses encompass various segments within the medical field, including Interventional Cardiology & Radiology, Women's Health, Oncology, Patient Environment and Medical Infrastructure, OR Infrastructure & Projects, Respiratory Therapy, Vision & Eye Care, ICU, Anesthesia, Emergency Medicine, Endoscopy, Fluid Management, and Pain Management.
It's worth noting that the company has not disclosed its last investment or the involved investors, suggesting a potential opportunity for venture capitalists seeking involvement in the MedTech sector. As Medtechnica continues to build on its legacy and pursue innovation within the health care space, it presents an intriguing prospect for potential investors seeking to align with a company that prioritizes meaningful advancements in medical technology.
